F. Giorgino

Patient-Reported Outcomes Following Initiation or Simplification of Treatment With iGlarLixi in Adults With Type 2 Diabetes: A Narrative Review.

INTRODUCTION Given the significant burden that diabetes self-management poses, it is important to assess patient-reported outcomes (PROs) for Type 2 diabetes (T2D) treatments in clinical trials and real-world studies. Complex insulin regimens are associated with increased risk of hypoglycaemia and body weight gain, whi...

Diagnosis and management of polycystic ovary syndrome/polyendocrine metabolic ovarian syndrome: unmet needs and areas of clinical confidence among European endocrinologists.

The Smart MDI System in People With Type 1 Diabetes and High HBA1C: A Randomized Controlled Trial Demonstrating That Response to Alerts Drives Outcomes.

AIMS The aim was to assess the efficacy and safety of the smart multiple daily injections (MDI) system versus MDI plus continuous glucose monitor (CGM) in people with Type 1 diabetes and HbA1c ≥ 8%. MATERIAL AND METHODS After a 3-week run-in, 143 participants were randomized to Smart MDI or MDI + CGM. The primary end...